Position in HCM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$58,405
+$18,612 QoQ
Shares Held
5,428
+104.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 56 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HCM Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $624,876,791 across 66 Drug Manufacturers - Specialty & Generic names. HCM ranks #37 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDY |
Dr Reddys Laboratories Ltd
|
9,213,269 | $133,500,266 | |
| 2 | ZTS |
Zoetis Inc.
|
1,828,326 | $131,383,499 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
583,476 | $98,339,041 | |
| 4 | BHC |
Bausch Health Companies Inc.
|
10,832,582 | $53,404,627 | |
| 5 | VTRS |
Viatris Inc
|
3,135,460 | $49,791,098 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
62,600 | $33,918,552 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
953,413 | $32,301,629 | |
| 8 | HLN |
Haleon plc
|
3,385,489 | $31,586,609 |
All Filings in HCM
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $58,405 | 5,428 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $39,793 | 2,660 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $79,620 | 5,973 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $85,018 | 5,398 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $41,868 | 2,782 | Shares | Defined | 2025-11-21 | |
| 2024-09-30 | $1,953 | 100 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,553 | 266 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $1,730 | 103 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $7,895 | 436 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $77,144 | 4,554 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $51,768 | 4,314 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $136,904 | 10,515 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $218,861 | 14,808 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $118,147 | 13,335 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,196,437 | 94,655 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,535,165 | 133,994 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,415,553 | 125,871 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,426,623 | 120,913 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,228,435 | 107,676 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,611,458 | 92,441 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $2,582,636 | 80,657 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $2,242,716 | 69,434 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,584,828 | 57,463 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $893,748 | 50,070 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||